Objective To evaluate the preliminary results for patients treated with combined photodynamic therapy (PDT)with verteporfin and intravitreal bevacizumab (Avastin)for choroidal neovascularization (CNV)diseases.Methods This is a retrospective series of 29 cases (29 eyes)with juxtafoveal or subfoveal CNV. Patients were treated with PDT with verteporfin and 1.5 mg (0.06ml)of intravitrcal bevacizumab. Among them there were 15 cases of age-related macular degenerizatiun(AMD)with an average age of 63.3,of which 10 cases were male and 5 cases were female. Two cases of AMD accepted one PDT before treatment and the other were naive to treatment. Another 14 cases were the young patients with idiopathic CNV (ICNV)with an average age of 28, of which 6 cases were male and 8 cases were female. One case of ICNV accepted two PDT before treatment and the other were naive to treatment. All the patients